IP Library Granted Patent US 8,758,811
Granted Patent B2
US 8,758,811 · App. 12/952,094 · Granted Jun 24, 2014

Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery

Inventors: Ja-An Ho (Hsinchu, TW); Li-Sheng Wang (Hsinchu, TW); Chia-Min Yang (Hsinchu, TW); Li-Chen Wu (Nantou, TW)
Assignee: National Tsing Hua University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,758,811
App. No.
12/952,094
Granted
Jun 24, 2014
Kind
B2
Abstract

The present invention provides a multilayer vehicle, including a mesoporous silica core and a lipid bilayer coating thereon. Hydrophobic molecules are formed between the silica core and lipid layer. Additionally, methods and uses of the multilayer vehicle are also provided.

Claims (11)

1. A multilayer vehicle, comprising:

a mesoporous silica core;

a 13-(chlorodimethylsilylmethyl)-heptacosane layer having a first terminal conjugated to a surface of the silica nanoparticle; and

a lipid monolayer modified on a second terminal of the hydrophobic molecule.

2. The multilayer vehicle according to claim 1 , wherein the silica nanoparticle has a pore ranged between 2 nm and 50 nm.

3. The multilayer vehicle according to claim 1 , wherein the lipid layer has a surface comprising a functional molecule.

4. The multilayer vehicle according to claim 3 , wherein the functional molecule comprises a target molecule, a genomic material, an aptamer, a protein, an antibody, a contrast agent and a folic acid.

5. The multilayer vehicle according to claim 2 further comprising an active material encapsulated in the pore of the silica nanoparticle.

6. The multilayer vehicle according to claim 5 , wherein the active material is one selected from a group consisting of a drug, a fluorescent agent, a protein, a polypeptide, an antibody, a radioactive material, a growth factor, an aptamer, and a genomic material.

7. The multilayer vehicle according to claim 5 , wherein the multilayer vehicle is a nanoshuttle.

8. The multilayer vehicle according to claim 7 , wherein the nanoshuttle is delivered by one selected from a group consisting of an oral administration, a transdermal, an injection and an inhalation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2010
From: HO, JA-AN; WANG, LI-SHENG; YANG, CHIA-MIN; WU, LI-CHEN
To: NATIONAL TSING HUA UNIVERSITY
Reel/Frame 025397/0795 →
Priority Claims (1)
TW 098139728 A · Nov 23, 2009 · national
Continuity (1)
Related Publication 20110123601A1 · May 26, 2011